Christopher Mutz Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 months ago
Christopher Mutz has an estimated net worth of at least $11.2 million*, as of Oct. 29, 2025. They own 91,309 shares of ANIP stock. They have sold 42,157 shares of ANIP stock since 2021, for an estimated $1.2 million.
Christopher Mutz $ANIP SEC Form 4 Insider Trading
Christopher Mutz has filed a total of 11 insider trades in $ANIP since 2021. Their most recent trade was a sale of 3,162 shares, made on Mar 13, 2026. Their largest trade was a sale of 7,032 shares, made on Feb 12, 2026. We estimate that they now own 91,309 shares of $ANIP, worth an estimated $10.0 million.
Insider Trading at $ANIP
There have been a total of 178 insider trades reported at $ANIP since 2021, with 38,796 shares purchased and 2.1 million shares sold. The most active insider traders in $ANIP stock have been Muthusamy Shanmugam, Meredith Cook, and Chad Gassert. The most recent trade was a sale of 4,772 shares reported by Thomas Andrew Rowland (SVP, HEAD - ESTABLISHED BRANDS), made on Mar 11, 2026.
History of Insider Stock Trades by Christopher Mutz
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ANIP
|
Sale | 3,162 | Mar 13, 2026 | March 13, 2026, 5:28 p.m. |
|
ANIP
|
Sale | 3,602 | Mar 09, 2026 | March 10, 2026, 4:17 p.m. |
|
ANIP
|
Sale | 2,121 | Mar 06, 2026 | March 10, 2026, 4:17 p.m. |
|
ANIP
|
Sale | 417 | Mar 02, 2026 | March 4, 2026, 7:46 p.m. |
|
ANIP
|
Sale | 5,323 | Feb 20, 2026 | Feb. 23, 2026, 6:31 p.m. |
|
ANIP
|
Sale | 7,032 | Feb 12, 2026 | Feb. 17, 2026, 5:08 p.m. |
|
ANIP
|
Sale | 4,000 | May 14, 2025 | May 15, 2025, 8:10 p.m. |
|
ANIP
|
Sale | 6,500 | Nov 15, 2024 | Nov. 18, 2024, 5:03 p.m. |
|
ANIP
|
Sale | 2,000 | May 21, 2024 | May 22, 2024, 6:14 p.m. |
|
ANIP
|
Sale | 5,000 | Mar 05, 2024 | March 6, 2024, 5:24 p.m. |
|
ANIP
|
Sale | 3,000 | Nov 10, 2023 | Nov. 13, 2023, 5:02 p.m. |
$ANIP Executives and Stock Owners with Insider Trades
-
Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM OPS
-
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC.
-
Chad Gassert, SVP - CORP. DEV. & STRATEGY
-
Krista Davis, SVP, CHIEF HR OFFICER
-
Christopher Mutz, HEAD OF RARE DISEASE
-
Nikhil Lalwani, PRESIDENT & CEO
-
Ori Gutwerg, SVP, GENERICS
-
Stephen P. Carey, SVP & CFO
-
James G. Marken, SVP OPS & PROD DEV
-
Thomas Andrew Rowland, SVP, HEAD - ESTABLISHED BRANDS
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.